Most Recent
Novartis appeals IP win for Pharmacor over blood pressure drug
Appeals 2025-01-20 11:42 pm By Christine Caulfield

Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘What’s done is done’: Judge defers penalty hearing in Harvey Norman case
Competition & Consumer Protection 2025-01-17 3:04 pm By Sam Matthews

A judge has deferred the question of what penalties Harvey Norman and Latitude Finance should face in a case by ASIC until their appeals are heard, noting the ā€œregrettableā€ fragmentation of the case.Ā 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Katy Perry wins appeal in trade mark fight with Aussie designer
Intellectual Property 2024-11-22 11:55 pm By Sam Matthews

The Full Court has overturned a finding that singer Katy Perry infringed an Australian fashion designer’s ‘Katie Perry’ mark, finding the designer knew of the pop star when she registered the mark.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

CBA slams class actions’ ‘misguided’ theory on appeal
Class Actions 2024-11-19 11:03 pm By Sam Matthews

CBA has attacked two failed class actions’ “misguided” appeal, arguing that requiring companies to disclose incomplete information to shareholders would distort the market.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis loses case against Pharmacor over blood pressure drug
Intellectual Property 2024-11-13 11:44 pm By Sam Matthews

Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer’s patents for blockbuster blood thinner Xarelto invalid: court
Intellectual Property 2024-10-23 11:45 pm By Sam Matthews

Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ASIC wins case against Harvey Norman over ‘interest-free’ ads
Judgment 2024-10-18 12:07 pm By Sam Matthews

A judge on Friday rejected Latitude Finance’s defence in ASIC’s case over Harvey Norman’s ‘interest-free’ ads that no reasonable consumer would expect ā€œa charitable free lunchā€.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

CBA class actions win halt to costs battle pending appeal
Appeals 2024-09-23 2:45 pm By Cindy Cameronne

Applicants in two dismissed class actions against the Commonwealth Bank have secured an order staying an assessment of costs in the failed cases until the outcome of an appeal.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Failed CBA class actions want to stay fight over costs
Class Actions 2024-09-19 3:26 pm By Cindy Cameronne

Two failed shareholder class actions against the Commonwealth Bank of Australia want to delay paying the bank’s costs until after their 62-ground appeal is heard.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge strikes out ACCC’s entire claim against Meta over crypto ads
Competition & Consumer Protection 2024-09-06 12:25 pm By Cindy Cameronne

Over objections from the ACCC, a judge has struck out the regulator’s entire case against Meta over scam cryptocurrency ads on Facebook after it clarified that each allegedly misleading ad should be a separate contravention.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?